Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Life After Chapter 11? Here Are 5 Big Brands That Survived

By Jeff Reeves Jan 25, 2012

Hang in there, Kodak. Bankruptcy doesn't have to mean the end. Here are five well-known names that came back from the brink of disaster.

Apple Proves (Again) It’s Wall Street’s No. 1 Growth Stock

By Jeff Reeves Jan 24, 2012

Apple earnings came in with a stunning 118% jump on Tuesday after the bell, proving it still can tally mammoth growth -- and might be a steal even at $450.

Apple Reports Earnings Doubler! – Tuesday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger Jan 24, 2012

Apple (AAPL) reported first-quarter earnings growth of 118% on Tuesday, sending its stock up almost 9% in early after-hours trading.

JPMorgan CEO Jamie Dimon: Bernanke and Geithner ‘Saved the System’

By Jeff Reeves Jan 24, 2012

On Tuesday, Fox Business anchor Charlie Gasparino grilled JPMorgan Chase (JPM) CEO Jamie Dimon at the financial company's New York headquarters.

Why I Couldn’t Care Less About Apple’s Earnings Report

By Louis Navellier, Editor, Growth Investor Jan 24, 2012

Whatever news comes out regarding Apple's earnings, this company will continue to dominate the consumer electronics industry for years to come.

Halliburton: Solid Earnings, Mixed Outlook

By Louis Navellier, Editor, Growth Investor Jan 24, 2012

Material, labor and logistics costs could rise, but overall, energy stocks are a screaming buy. The ride will be bumpy, the trend is solidly up.

Gold, Silver Slightly Lower on European Bond Swap Rejection

By Andrew Burger, InvestorPlace Contributor Jan 24, 2012

Lower gold and silver prices also were dragging down most miners Tuesday morning, though NovaGold Resources was level to slightly up.

7 Attractive Stocks to Watch

By Bryan Perry Jan 24, 2012

They're not ready to buy just yet, but here's how to read the economy, their share prices and their dividends to know when they will be.

Macy’s Hauls Martha Stewart Into Court

By InvestorPlace Staff Jan 24, 2012

Martha Stewart Living Omnimedia's new deal with J.C. Penney has Macy's in a litigious dither, claiming a violation of its own agreement with Stewart.

Starbucks’ Addition of Booze Is a Snooze

By James Brumley, InvestorPlace Feature Writer Jan 24, 2012

Beer and wine at Starbucks? Sounds exciting! But considering the small sample size -- and a potential clash in clientele -- investors shouldn't plan around it.

McDonald’s, Verizon Highlight Big Morning of Earnings Reports

By InvestorPlace Staff Jan 24, 2012

McDonald's posted another earnings beat on strength across the globe, but Verizon fell short. See how DuPont, Johnson & Johnson and Travelers made out.

Energy Stocks Get a Jolt — Monday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger Jan 23, 2012

Chesapeake Energy (CHK) announces major cutbacks in natural gas production, sending gas and coal producers higher Monday.

RIM’s Heins Quickly Lodges Foot in Mouth

By Tom Taulli, InvestorPlace Contributor Jan 23, 2012

Research In Motion's new CEO might go down in history with the Titanic and Costa Concordia captains by dropping a quote that could go down in bonehead-statement history.

Earnings Duds and Earnings Studs

By Louis Navellier, Editor, Growth Investor Jan 23, 2012

Find out which companies outperformed and which companies missed earnings expectations last week.

Gold, Silver Start the Week Climbing

By Andrew Burger, InvestorPlace Contributor Jan 23, 2012

Increases in gold and silver prices were driving most miners higher, too, though Pan American Silver (PAAS) was getting killed after announcing an acquisition.

If Novartis’ MS Drug Falters, Biogen Will Gain

By Barry Cohen, Health Care Writer Jan 23, 2012

After the deaths of 11 people who were taking the drug, concerns that Gilenya may cause heart problems has hit NVS hard, ending the stock's months-long upswing.